DHR DANAHER CORP /DE/
Price Chart
Executive Summary
Piper Sandler initiated coverage on Danaher (DHR) at Neutral with a $200 price target, the lowest in the consensus range. The firm's 54% accuracy on 3,763 calls with a 3.6% average return gives it moderate credibility. The broader consensus is heavily bullish — 90% of analysts rate DHR a Buy (27 of 30), with a mean price target of $244.27 implying 33% upside from the current $183.63. Piper's $200 target sits 18% below the mean, reflecting a cautious view relative to peers. Over the past 30 days, analyst activity is balanced with one upgrade and one downgrade, while EPS revisions for the current year have been positive (2 up, 1 down). A major institutional buyer (Capital Research Global Investors) more than doubled its position, while short interest remains elevated at a 58.8% ratio. The neutral initiation from an average-accuracy firm does not significantly shift the strong bullish consensus.
Impact Score
Consensus & Targets
Of 30 analysts covering DHR, 27 rate it a Buy (11 Strong Buy, 16 Buy) and 3 rate it Hold — a 90% Buy rating. No Sell ratings exist, making consensus overwhelmingly bullish. Piper's Neutral stance is a contrarian break from the majority view.
The consensus mean price target is $244.27, median $245, high $310, and low $200. At $183.63, DHR trades at a 33% discount to the mean. Piper's $200 target is exactly the low of the range, implying only 8.9% upside — far less than the consensus implied gain.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-11 | Piper Sandler | initiate | Neutral | $200.00 |
| 2026-06-03 | HSBC | maintain | Buy | $230.00 |
| 2026-05-27 | Citigroup | downgrade | Neutral | $95.00 |
| 2026-04-23 | Morgan Stanley | maintain | Overweight | $255.00 |
| 2026-04-22 | UBS | maintain | Buy | $250.00 |
| 2026-04-22 | Wells Fargo | maintain | Equal-Weight | $212.00 |
| 2026-04-22 | Guggenheim | maintain | Buy | $235.00 |
| 2026-04-22 | Baird | maintain | Outperform | $245.00 |
| 2026-04-17 | Baird | maintain | Outperform | $249.00 |
| 2026-04-14 | Barclays | maintain | Overweight | $230.00 |
In the last 30 days, analyst activity shows 1 upgrade and 1 downgrade. Citigroup downgraded DHR from Buy to Neutral with a $95 target, and HSBC reaffirmed Buy with a $230 target. EPS revisions for the current fiscal year are net positive: 2 upward revisions in the past 7 days and 2 in the past 30 days, with only 1 downward revision. The earnings date is July 20, 2026, about five weeks out.
Firm Track Record — Piper Sandler
Piper Sandler accuracy: 54% on 3763 calls | avg return: 3.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Guggenheim | 100% | 2/2 | 6.9% | top tier |
| Evercore ISI Group | 75% | 3/4 | 3.3% | top tier |
| UBS | 67% | 2/3 | 3.3% | top tier |
| Baird | 63% | 5/8 | 1.3% | top tier |
| B of A Securities | 50% | 2/4 | 1.6% | below average |
| TD Cowen | 50% | 2/4 | 1.5% | below average |
| Wells Fargo | 40% | 2/5 | -4.2% | below average |
| Goldman Sachs | 33% | 1/3 | -5.5% | below average |
| Citigroup | 33% | 1/3 | -9.3% | below average |
| Barclays | 33% | 3/9 | 0.1% | below average |
Piper Sandler has a 54% accuracy rate across 3,763 calls with an average return of 3.6%. Compared to other firms covering DHR, Piper's accuracy is moderate — below top-tier firms like Guggenheim (100% on 2 calls) and Evercore (75% on 4), but above Barclays (33% on 9) and Raymond James (33% on 3).
Earnings Estimates
Next earnings: Jul 20, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $9.10 | $8.83 — $9.40 | $27.1B | ↑2 ↓0 |
| 0y | $8.44 | $8.38 — $8.49 | $25.5B | ↑2 ↓0 |
| 0q | $1.83 | $1.81 — $1.86 | $6.1B | ↑0 ↓0 |
| +1q | $2.03 | $1.94 — $2.12 | $6.3B | ↑0 ↓0 |
Cross-Platform Signals
Insider trading shows a single sell of $237k by an executive on May 1, a weak bearish signal. Congressional activity is minimal — a small buy by Rep. Michael McCaul (R-TX) for $1k-$15k. Institutional moves diverge: Capital Research Global Investors doubled its position (+1445.9%), while Norges Bank and AKRE Capital exited and Renaissance Technologies initiated a new stake. Short interest is elevated at a 58.8% ratio, suggesting persistent bearish sentiment among short sellers.
Actionable Insight
Piper's cautious initiation at the low-end PT is a modest contrarian call against a bullish consensus. Traders should monitor the July 20 earnings for catalyst; the heavy institutional buying from Capital Research is a supportive factor, but elevated short interest warrants caution.
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
ANALYST-UPGRADE
| $183.00 awaiting T+5 | awaiting T+5 | — | $180.10 (−1.58%) |
|
May 31, 2026
14d ago
|
ANALYST-UPGRADE
| $204.69 $189.99 | ▼ −7.18% | ▼ −7.81% | $180.10 (−12.01%) |
|
May 27, 2026
18d ago
|
ANALYST-DOWNGRADE
| $172.76 $176.11 | ▼ −1.94% | ▼ −0.73% | $180.10 (−4.25%) |
|
May 1, 2026
6w ago
|
ANALYST-UPGRADE
| $204.69 $189.99 | ▼ −7.18% | ▼ −7.81% | $180.10 (−12.01%) |
|
Apr 23, 2026
7w ago
|
424B5
| $177.12 $178.95 | ▲ +1.03% | ▲ +0.13% | $180.10 (+1.68%) |
|
Apr 22, 2026
7w ago
|
424B5
| $184.00 $177.94 | ▼ −3.29% | ▼ −3.35% | $180.10 (−2.12%) |
|
Apr 17, 2026
8w ago
|
8-K
| $194.24 $177.12 | ▼ −8.81% | ▼ −9.37% | $180.10 (−7.28%) |
|
Mar 25, 2026
11w ago
|
DEFA14A
| $186.98 $190.72 | ▲ +2.00% | ▲ +2.24% | $180.10 (−3.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access